We are live on ! Find out more
BJDX icon

Bluejay Diagnostics
BJDX

2 hedge funds and large institutions have $12.2K invested in Bluejay Diagnostics in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.32% less ownership

Funds ownership: 3.78% → 0.46% (-3.3%)

82% less funds holding

Funds holding: 11 → 2 (-9)

96% less capital inflows, than outflows

Capital inflows: $5.3K | Capital outflows: $120K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 9

Holders
2
Holders Change
-9
Holders Change %
-81.82%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$3.36K
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$1.94K

Top Sellers

Rank Fund Capital Flow
1
Anson Funds Management
Anson Funds Management
Texas
-$40.5K
2
SM
Sabby Management
Florida
-$38.8K
3
Renaissance Technologies
Renaissance Technologies
New York
-$17.4K
4
Two Sigma Securities
Two Sigma Securities
New York
-$6.68K
5
Citadel Advisors
Citadel Advisors
Florida
-$6.63K

BJDX Hedge Fund Activity: Q4 2024 in Review

2 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q4 2024, worth a combined $12.2K — down 91% from $129K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BJDX and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, adding an estimated $3.36K. The largest seller was Anson Funds Management, exiting entirely with an estimated $40.5K sold.

  • 2 institutional investors held Bluejay Diagnostics (BJDX) as of Q4 2024, down from 11 in Q3 2024.
  • Funds reported $12.2K of Bluejay Diagnostics stock for Q4 2024, down 91% quarter-over-quarter.
  • 0 funds opened new Bluejay Diagnostics positions in Q4 2024 and 9 closed out, a net change of -9 holders.
  • The largest Bluejay Diagnostics buyer in Q4 2024 was UBS Group, an estimated $3.36K added.
  • The largest Bluejay Diagnostics seller in Q4 2024 was Anson Funds Management, an estimated $40.5K sold.

Based on aggregated 13F filings for Q4 2024.